The Latest in ALL

Contaminated graft causes infection in ALL patient

January 30, 2018

ALL

Immunotherapy with less intense chemotherapy safe and effective for older patients with ALL

January 21, 2018

Children with pathogenic TP53 variants face increased risk of hard-to-treat ALL

January 16, 2018

ALL

Flu vaccine did not protect children with acute leukemia

December 11, 2017

CD22 CAR activity in B-ALL highlights promise of multispecific CARs

November 21, 2017

ALL

CAR T-cell therapy: Moving from cost to value

November 21, 2017

Cancer patients with TKI-induced hypothyroidism had better survival rates

November 15, 2017

In children with ALL, physical and emotional effects persist

November 13, 2017

Generic clofarabine injection hits the market

November 10, 2017

ALL

Cascade of costs could push new gene therapy above $1 million per patient

October 17, 2017

ALL

ALL therapies grow, so do the complexities of choosing the order of treatments

October 9, 2017

ALL

How would you treat ... recurrent pre-B ALL in a 24-year-old woman?

September 16, 2017

ALL

CB-5083 showed significant activity against B-ALL

September 9, 2017

ALL

FDA approves first gene therapy – tisagenlecleucel for ALL

August 30, 2017

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

August 23, 2017

ALL